Steven Blaine Holloway MD FACOG

Obstetrics & Gynecology•Dallas, TX

Gynecologic Oncology

Assistant Professor, University of Texas Southwestern

Join to View Full Profile

5323 Harry Hines BoulevardDallas, TX 75390
Phone+1 214-648-3026
Fax+1 214-645-2622

Summary

Dr. Steven Holloway is an Obstetrics & Gynecology specialist with a subspecialty in Gynecologic Oncology, based in Dallas, TX. He completed his residency and fellowship at the University of Texas Southwestern Medical Center, where he has also been employed as a physician since 2020. Dr. Holloway has been working at Parkland Health since 2016. His clinical experience includes gynecologic oncology and general obstetrics and gynecology. He has published research on topics such as the recurrence of early-stage cervical carcinoma, defining investigating subclassifications of cervical adenocarcinoma, and risk factors for surgical complications after radical oncologic surgery.

Education & Training

University of Texas Southwestern Medical CenterFellowship, Gynecologic Oncology, 2020 - 2024
University of Texas Southwestern Medical CenterResidency, Obstetrics and Gynecology, 2016 - 2020
McGovern Medical School at UTHealthClass of 2016

Certifications & Licensure

TX State Medical License 2019 - 2025

Publications & Presentations

PubMed

1 citations
Predicting VTE and utility of thromboprophylaxis in metastatic and recurrent cervical cancer.
Christopher A Walker, Carson Edwards, Don McIntire, Lydia Makepeace, Steven Blaine Holloway
Gynecologic Oncology. 2024-09-01
3 citations
Risk factors for catheter-associated urinary tract infections following radical hysterectomy for cervical cancer.
Alyssa J Mercadel, Steven B Holloway, Monica Saripella, Jayanthi S Lea
American Journal of Obstetrics and Gynecology. 2023-06-01
1 citations
Role for immunotherapy in pretreated, recurrent, metastatic squamous cell carcinoma arising from mature cystic teratoma.
Carson C Edwards, Steven Blaine Holloway, Shalini Sethi, Jayanthi S Lea
Gynecologic Oncology Reports. 2023-06-01

Journal Articles

Isolated para-aortic nodal recurrence after treatment of early stage cervical carcinoma
Holloway SB, Mercadel AJ, Miller DS, Lea JS, Gynecol Oncol, 3/2023
Risk Factors for Catheter-Associated Urinary Tract Infections Following Radical Hysterectomy for Cervical Cancer
Mercadel AJ*, Holloway SB*, Saripella M, Lea JS, Am J Obstet Gynecol, 2/2023
Predicting VTE and utility of thromboprophylaxis in metastatic and recurrent cervical cancer
Christopher A Walker, Carson Edwards, Don McIntire, Lydia Makepeace, Steven Blaine Holloway, Ev Kakadiaris, Alexandra N Spirtos, David S Miller, Jayanthi S Lea, Gynecologic Oncology, 6/2024
Cervical Adenocarcinoma: Histopathologic Features From Biopsies to Predict Tumor Behavior
Rivera-Colon G, Chen H, Niu S, Lucas E, Holloway SB, Carrick K, Gwin K, Lea J, Zheng W, Am J Surg Pathol, 2/2020
Tumor Necrotic Debris and High Nuclear Grade: Newly Identified High-risk Factors for Early-stage Endocervical Adenocarcinoma
Holloway SB, Colon GR, Zheng W, Lea JS, Am J Clin Oncol, 4/2021
Role for immunotherapy in pretreated, recurrent, metastatic squamous cell carcinoma arising from mature cystic teratoma
Edwards CC, Holloway SB, Sethi S, Lea JS, Gynecol Oncol Rep, 6/2023
Docetaxel treatment for widely metastatic invasive vulvar extramammary Paget’s disease with multifocal bone metastasis
Aroche-Gutierrez L, Holloway SB, Donthi D, Lea J, Gyn Oncol Reports, 12/2022
Tumoral Morphologic Features From Cervical Biopsies That Are Predictive of a Negligible Risk for Nodal Metastasis and Tumor Recurrence in Usual-type Cervical Adenocarc...
Wang Y, Chang R, Luo R-Z, Yu J, Zhang X, Yang X, Quddus MR, LI L, Yang W, Liu A, Jiang Q, Zhao R, Zhu H, Zhou F, Wang Y, Sheng X, Liu L-L, Wen Y-L, Banet N, Sung CJ, Q..., Am J Surg Pathol, 5/2022
Join now to see all